Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

XOMA Royalty (XOMA) Cash & Equivalents: 2015-2025

Historic Cash & Equivalents for Royalty (XOMA) over the last 11 years, with Sep 2025 value amounting to $45.2 million.

  • Royalty's Cash & Equivalents fell 68.19% to $45.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.2 million, marking a year-over-year decrease of 68.19%. This contributed to the annual value of $101.7 million for FY2024, which is 33.69% down from last year.
  • As of Q3 2025, Royalty's Cash & Equivalents stood at $45.2 million, which was down 39.80% from $75.1 million recorded in Q2 2025.
  • Over the past 5 years, Royalty's Cash & Equivalents peaked at $153.3 million during Q4 2023, and registered a low of $31.4 million during Q2 2023.
  • In the last 3 years, Royalty's Cash & Equivalents had a median value of $90.3 million in 2025 and averaged $90.6 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first skyrocketed by 357.64% in 2024, then slumped by 68.19% in 2025.
  • Royalty's Cash & Equivalents (Quarterly) stood at $93.3 million in 2021, then crashed by 38.04% to $57.8 million in 2022, then skyrocketed by 165.09% to $153.3 million in 2023, then slumped by 33.69% to $101.7 million in 2024, then plummeted by 68.19% to $45.2 million in 2025.
  • Its Cash & Equivalents stands at $45.2 million for Q3 2025, versus $75.1 million for Q2 2025 and $90.3 million for Q1 2025.